Results 201 to 210 of about 55,411 (257)

Metachronous Pheochromocytoma and Cholangiocarcinoma in a patient with Neurofibromatosis type 1: a case report. [PDF]

Oxf Med Case Reports
Al Harrak Y, Lkhoyaali S, Lamsyah O, Boutayeb S, El Ghissassi I, M'rabti H, Errihani H.   +6 more
europepmc   +1 more source

Diagnostic and Treatment Strategies for Adult Non-Ossifying Fibromas: A Case Report and Literature Review. [PDF]

Am J Case Rep
Zhao Z, Li J, Wu S.
europepmc   +1 more source

Translation and Cultural Adaptation of the PedsQL Neurofibromatosis Module, Version 3.0, Into Brazilian Portuguese. [PDF]

Cureus
Oliveira Machado M, de Lima FT, do Nascimento AS, Saba NS, Capellano AM, Monteiro Caran E.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neurofibromatosis 2

Otolaryngologic Clinics of North America, 2012
A comprehensive discussion of neurofibromatosis 2 (NF2) is presented, including clinical characteristics, symptoms, diagnosis, tumor types, prevalence and incidence, genetic testing, imaging, treatment options, and follow-up management of NF2.
Michael, Hoa, William H, Slattery
  +5 more sources

Neurofibromatosis 2

Current Opinion in Neurology, 2003
Recent clinical and molecular research on neurofibromatosis 2 (NF2) is reviewed, and the implications for clinical practice and research are discussed.NF2 patients who are treated in specialty centers have a significantly lower risk of mortality than those who are treated in non-specialty centers. Vestibular schwannoma growth rates in NF2 are generally
Michael E, Baser, D Gareth, R Evans, David H, Gutmann   +2 more
openaire   +2 more sources